(Q40708171)
Statements
Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia (English)
Julio C Chavez
Miguel Piris-Villaespesa
Samir Dalia
Elyce Turba
Lisa Nodzon
Rami Komrokji
Lubomir Sokol
Frederick L Locke
Jeffrey Lancet
Eduardo M Sotomayor
Mohamed A Kharfan-Dabaja
Javier Pinilla-Ibarz